News
Why Corcept Therapeutics’ Relacorilant Fell Short And What It Means For The Company
This article was written byFollowBioTechAnalyzer is a research and analytics platform focused on making complex FDA-related biotechnology information clear, accessible,…
Editor's Top Picks
Goldman Sachs Emerging Markets Equity Insights Fund Q3 2025 Commentary
Market Review In the third quarter of 2025, the MSCI Emerging Markets Index rose by 10.64%, contributing to the strongest…
Your one-stop resource for personal news and tips.
More form News
Population undercounting threatens public policy, scientists warn
Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories…
More than 13mn people in Africa could catch malaria owing to proposed US cuts
Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories…
Tesla’s robotaxi ambitions face a reality check after launch
Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories…
Canada to curb steel and aluminium imports to protect jobs
Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories…
How Mark Zuckerberg unleashed his inner brawler
José Lucas Costa da Silva peered over towards the warm up area for the Brazilian…
Ex-Janus Henderson analyst guilty of insider dealing as he worked from home
Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories…
Gulf monarchies hold rival Iran close as Israel conflict rages
Arab monarchies are seeking to stay close to their regional rival Tehran as they frantically…
Europeans to hold last-ditch talks with Iran as Trump weighs entering war
Unlock the White House Watch newsletter for freeYour guide to what Trump’s second term means…
US weighs risks of Iranian retaliation
As Donald Trump huddles with advisers in the White House’s situation room weighing whether to…
How Trump can offer Iran a way out
Unlock the White House Watch newsletter for freeYour guide to what Trump’s second term means…
Swiss central bank cuts interest rates to zero
Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories…
Elon Musk’s X to offer investment and trading in ‘super app’ push
Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories…
Bank of England holds rates at 4.25% amid Middle East uncertainty
Stay informed with free updatesSimply sign up to the UK interest rates myFT Digest --…
Russia on brink of recession, says economy minister
Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories…
Trafigura’s projects boss to leave in latest senior departure
Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories…